{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:13:23Z","timestamp":1790104403936,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s00108-021-01218-3","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T14:02:48Z","timestamp":1641823368000},"page":"51-61","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Reizdarmsyndrom und funktionelle Dyspepsie","Irritable bowel syndrome and functional dyspepsia"],"prefix":"10.1007","volume":"63","author":[{"given":"L.","family":"Gottschalk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Andresen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Layer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,10]]},"reference":[{"key":"1218_CR1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.031","author":"F Mearin","year":"2016","unstructured":"Mearin\u00a0F, Lacy\u00a0BE, Chang\u00a0L et\u00a0al (2016) Bowel disorders. Gastroenterology. https:\/\/doi.org\/10.1053\/j.gastro.2016.02.031","journal-title":"Gastroenterology"},{"key":"1218_CR2","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1055\/s-0029-1245976","volume":"49","author":"P Layer","year":"2011","unstructured":"Layer\u00a0P, Andresen\u00a0V, Pehl\u00a0C et\u00a0al (2011) Irritable bowel syndrome: German consensus guidelines on definition, pathophysiology and management. Z\u00a0Gastroenterol 49:237\u2013293","journal-title":"Z Gastroenterol"},{"issue":"6","key":"1218_CR3","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1053\/j.gastro.2016.02.011","volume":"150","author":"V Stanghellini","year":"2016","unstructured":"Stanghellini\u00a0V, Chan\u00a0FK, Hasler\u00a0WL, Malagelada\u00a0JR, Suzuki\u00a0H, Tack\u00a0J et\u00a0al (2016) Gastroduodenal disorders. Gastroenterology 150(6):1380\u20131392","journal-title":"Gastroenterology"},{"issue":"1","key":"1218_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1159\/000485409","volume":"35","author":"G Holtmann","year":"2017","unstructured":"Holtmann\u00a0G, Shah\u00a0A, Morrison\u00a0M (2017) Pathophysiology of functional gastrointestinal disorders: a\u00a0holistic overview. Dig Dis 35(1):5\u201313","journal-title":"Dig Dis"},{"key":"1218_CR5","series-title":"Facharztwissen Gastroenterologie","first-page":"561","volume-title":"Funktionelle Erkrankungen","author":"V Andresen","year":"2017","unstructured":"Andresen\u00a0V et\u00a0al (2017) Funktionelle Erkrankungen. Facharztwissen Gastroenterologie. Elsevier, M\u00fcnchen, S\u00a0561"},{"issue":"10","key":"1218_CR6","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1055\/s-0041-101692","volume":"140","author":"J Keller","year":"2015","unstructured":"Keller\u00a0J, Layer\u00a0P (2015) Chronische Oberbauchschmerzen: Diagnostischer und therapeutischer Algorithmus. Dtsch Med Wochenschr 140(10):718\u2013722","journal-title":"Dtsch Med Wochenschr"},{"key":"1218_CR7","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.028","author":"G Barbara","year":"2016","unstructured":"Barbara\u00a0G, Feinle-Bisset\u00a0C, Ghoshal\u00a0UC et al (2016) The intestinal microenvironment and functional gastrointestinal disorders. Gastroenterology. https:\/\/doi.org\/10.1053\/j.gastro.2016.02.028","journal-title":"Gastroenterology"},{"key":"1218_CR8","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.027","author":"L Van Oudenhove","year":"2016","unstructured":"Van Oudenhove\u00a0L, Crowell\u00a0MD, Drossman\u00a0DA, Halpert\u00a0AD, Keefer\u00a0L, Lackner\u00a0JM et\u00a0al (2016) Biopsychosocial aspects of functional gastrointestinal disorders. Gastroenterology. https:\/\/doi.org\/10.1053\/j.gastro.2016.02.027","journal-title":"Gastroenterology"},{"key":"1218_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/2050640615581113","volume":"4","author":"V Andresen","year":"2016","unstructured":"Andresen\u00a0V, Lowe\u00a0B, Broicher\u00a0W et al (2016) Post-infectious irritable bowel syndrome (PI-IBS) after infection with Shiga-like toxin-producing escherichia coli (STEC) O104:H4: a cohort study with prospective follow-up. United European Gastroenterol j 4:121\u2013131","journal-title":"United European Gastroenterol j"},{"key":"1218_CR10","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1053\/j.gastro.2016.12.039","volume":"152","author":"F Klem","year":"2017","unstructured":"Klem\u00a0F, Wadhwa\u00a0A, Prokop\u00a0LJ et\u00a0al (2017) Prevalence, risk factors, and outcomes of irritable bowel syndrome after infectious enteritis: a systematic review and metaanalysis. Gastroenterology 152:1042\u20131054.e1","journal-title":"Gastroenterology"},{"issue":"11","key":"1218_CR11","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1038\/ajg.2017.264","volume":"112","author":"SJ Park","year":"2017","unstructured":"Park\u00a0SJ, Acosta\u00a0A, Camilleri\u00a0M, Burton\u00a0D, Harmsen\u00a0WS, Fox\u00a0J et\u00a0al (2017) Gastric motor dysfunction in patients with functional gastroduodenal symptoms. Am J Gastroenterol 112(11):1689\u20131699","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"1218_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1136\/gutjnl-2016-312361","volume":"67","author":"M Simr\u00e9n","year":"2018","unstructured":"Simr\u00e9n\u00a0M, T\u00f6rnblom\u00a0H, Palsson\u00a0OS, van Tilburg\u00a0MAL, Van Oudenhove\u00a0L, Tack\u00a0J et\u00a0al (2018) Visceral hypersensitivity is associated with GI symptom severity in functional GI disorders: consistent findings from five different patient cohorts. Gut 67(2):255\u2013262","journal-title":"Gut"},{"issue":"7","key":"1218_CR13","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/ajg.2015.128","volume":"110","author":"MI Pinto-Sanchez","year":"2015","unstructured":"Pinto-Sanchez\u00a0MI, Ford\u00a0AC, Avila\u00a0CA, Verdu\u00a0EF, Collins\u00a0SM, Morgan\u00a0D et al (2015) Anxiety and depression increase in a\u00a0stepwise manner in parallel with multiple FGIDs and symptom severity and frequency. Am J Gastroenterol 110(7):1038\u20131048","journal-title":"Am J Gastroenterol"},{"key":"1218_CR14","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/apt.13145","volume":"41","author":"V Miller","year":"2015","unstructured":"Miller\u00a0V, Carruthers\u00a0HR, Morris\u00a0J et\u00a0al (2015) Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients. Aliment Pharmacol Ther 41:844\u2013855","journal-title":"Aliment Pharmacol Ther"},{"key":"1218_CR15","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/ajg.2014.148","volume":"109","author":"AC Ford","year":"2014","unstructured":"Ford\u00a0AC, Quigley\u00a0EM, Lacy\u00a0BE et al (2014) Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol 109:1350\u20131365 (quiz 1366)","journal-title":"Am J Gastroenterol"},{"key":"1218_CR16","first-page":"Cd003460","volume":"8","author":"L Ruepert","year":"2011","unstructured":"Ruepert\u00a0L, Quartero\u00a0AO, de Wit\u00a0NJ et\u00a0al (2011) Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev 8:Cd3460","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"1218_CR17","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/MCG.0b013e3182a88357","volume":"48","author":"R Khanna","year":"2014","unstructured":"Khanna\u00a0R, MacDonald\u00a0JK, Levesque\u00a0BG (2014) Peppermintoil for the treatment of irritable bowel syndrome: a\u00a0systematic review and meta-analysis. J\u00a0Clin Gastroenterol 48(6):505\u2013512","journal-title":"J Clin Gastroenterol"},{"issue":"9","key":"1218_CR18","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/ajg.2014.148","volume":"109","author":"AC Ford","year":"2014","unstructured":"Ford\u00a0AC, Quigley\u00a0EM, Lacy\u00a0BE, Lembo\u00a0AJ, Saito\u00a0YA, Schiller\u00a0LR et al (2014) Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol 109(9):1350\u20131365 (quiz 66)","journal-title":"Am. J. Gastroenterol."},{"issue":"9","key":"1218_CR19","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1038\/ajg.2013.197","volume":"108","author":"RW Chapman","year":"2013","unstructured":"Chapman\u00a0RW, Stanghellini\u00a0V, Geraint\u00a0M, Halphen\u00a0M (2013) Randomized clinical trial: macrogol\/PEG 3350 plus electrolytes for treatment of patients with constipation associated with irritable bowel syndrome. Am J Gastroenterol 108(9):1508\u20131515","journal-title":"Am J Gastroenterol"},{"key":"1218_CR20","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1038\/ajg.2014.202","volume":"109","author":"AC Ford","year":"2014","unstructured":"Ford\u00a0AC, Quigley\u00a0EM, Lacy\u00a0BE et al (2014) Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol 109:1547\u20131561 (quiz 1546, 1562)","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"1218_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/nmo.12217","volume":"26","author":"J Tack","year":"2014","unstructured":"Tack\u00a0J, Stanghellini\u00a0V, Dubois\u00a0D, Joseph\u00a0A, Vandeplassche\u00a0L, Kerstens\u00a0R (2014) Effect of prucalopride on symptoms of chronic constipation. Neurogastroenterol Motil 26(1):21\u201327","journal-title":"Neurogastroenterol Motil"},{"key":"1218_CR22","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/nmo.12292","volume":"26","author":"DK Atluri","year":"2014","unstructured":"Atluri\u00a0DK, Chandar\u00a0AK, Bharucha\u00a0AE et al (2014) Effect of linaclotide in irritable bowel syndrome with constipation (IBS-C): a\u00a0systematic review and meta-analysis. Neurogastroenterol Motil 26:499\u2013509","journal-title":"Neurogastroenterol Motil"},{"key":"1218_CR23","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.cgh.2007.12.015","volume":"6","author":"V Andresen","year":"2008","unstructured":"Andresen\u00a0V, Montori\u00a0VM, Keller\u00a0J et al (2008) Effects of 5\u2011hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a\u00a0systematic review and meta-analysis of randomized controlled trials. Clin Gastroenterol Hepatol 6:545\u2013555","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1218_CR24","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1136\/gutjnl-2013-305989","volume":"63","author":"K Garsed","year":"2014","unstructured":"Garsed\u00a0K, Chernova\u00a0J, Hastings\u00a0M et\u00a0al (2014) A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea. Gut 63:1617\u20131625","journal-title":"Gut"},{"issue":"1","key":"1218_CR25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/NEJMoa1004409","volume":"364","author":"M Pimentel","year":"2011","unstructured":"Pimentel\u00a0M, Lembo\u00a0A, Chey\u00a0WD, Zakko\u00a0S, Ringel\u00a0Y, Yu\u00a0J et\u00a0al (2011) Rifaximin therapy for patients with irritable bowel syndrome without constipation. N\u00a0Engl J Med 364(1):22\u201332","journal-title":"N Engl J Med"},{"key":"1218_CR26","first-page":"131","volume":"9","author":"WS Nanayakkara","year":"2016","unstructured":"Nanayakkara\u00a0WS, Skidmore\u00a0PM, O\u2019Brien\u00a0L et\u00a0al (2016) Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date. Clin Exp Gastroenterol 9:131\u2013142","journal-title":"Clin Exp Gastroenterol"},{"issue":"11","key":"1218_CR27","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.amjmed.2004.01.008","volume":"116","author":"DA Peura","year":"2004","unstructured":"Peura\u00a0DA, Kovacs\u00a0TO, Metz\u00a0DC, Siepman\u00a0N, Pilmer\u00a0BL, Talley\u00a0NJ (2004) Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials. Am J Med 116(11):740\u2013748","journal-title":"Am J Med"},{"issue":"9","key":"1218_CR28","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1046\/j.1365-2036.2001.01044.x","volume":"15","author":"HA Redstone","year":"2001","unstructured":"Redstone\u00a0HA, Barrowman\u00a0N, Veldhuyzen Van Zanten\u00a0SJ (2001) H2-receptor antagonists in the treatment of functional (nonulcer) dyspepsia: a\u00a0meta-analysis of randomized controlled clinical trials. Aliment Pharmacol Ther 15(9):1291\u20131299","journal-title":"Aliment Pharmacol Ther"},{"issue":"13","key":"1218_CR29","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.3748\/wjg.v18.i13.1517","volume":"18","author":"M Sakaguchi","year":"2012","unstructured":"Sakaguchi\u00a0M, Takao\u00a0M, Ohyama\u00a0Y, Oka\u00a0H, Yamashita\u00a0H, Fukuchi\u00a0T et al (2012) Comparison of PPIs and H2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia. World J Gastroenterol 18(13):1517\u20131524","journal-title":"World J Gastroenterol"},{"issue":"12","key":"1218_CR30","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1111\/j.1572-0241.2003.08724.x","volume":"98","author":"P Moayyedi","year":"2003","unstructured":"Moayyedi\u00a0P, Deeks\u00a0J, Talley\u00a0NJ, Delaney\u00a0B, Forman\u00a0D (2003) An update of the Cochrane systematic review of helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews. Am J Gastroenterol 98(12):2621\u20132626","journal-title":"Am J Gastroenterol"},{"issue":"21","key":"1218_CR31","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1001\/archinternmed.2011.533","volume":"171","author":"LE Mazzoleni","year":"2011","unstructured":"Mazzoleni\u00a0LE, Sander\u00a0GB, Francesconi\u00a0CF, Mazzoleni\u00a0F, Uchoa\u00a0DM, De Bona\u00a0LR et\u00a0al (2011) Helicobacter pylori eradication in functional dyspepsia: HEROES trial. Arch Intern Med 171(21):1929\u20131936","journal-title":"Arch Intern Med"},{"issue":"12","key":"1218_CR32","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.3748\/wjg.v22.i12.3486","volume":"22","author":"LJ Du","year":"2016","unstructured":"Du\u00a0LJ, Chen\u00a0BR, Kim\u00a0JJ, Kim\u00a0S, Shen\u00a0JH, Dai\u00a0N (2016) Helicobacter pylori eradication therapy for functional dyspepsia: systematic review and meta-analysis. World J Gastroenterol 22(12):3486\u20133495","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"1218_CR33","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1055\/s-0042-102967","volume":"54","author":"W Fischbach","year":"2016","unstructured":"Fischbach\u00a0W, Malfertheiner\u00a0P, Lynen Jansen\u00a0P, Bolten\u00a0W, Bornschein\u00a0J, Buderus\u00a0S et al (2016) S2k-Leitlinie Helicobacter pylori und gastroduodenale Ulkuskrankheit. Z\u00a0Gastroenterol 54(4):327\u2013363","journal-title":"Z Gastroenterol"},{"issue":"1","key":"1218_CR34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12876-017-0639-0","volume":"17","author":"YJ Yang","year":"2017","unstructured":"Yang\u00a0YJ, Bang\u00a0CS, Baik\u00a0GH, Park\u00a0TY, Shin\u00a0SP, Suk\u00a0KT et al (2017) Prokinetics for the treatment of functional dyspepsia: Bayesian network meta-analysis. BMC Gastroenterol 17(1):83","journal-title":"BMC Gastroenterol"},{"issue":"11\u201312","key":"1218_CR35","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/j.1365-2036.2004.02275.x","volume":"20","author":"J Melzer","year":"2004","unstructured":"Melzer\u00a0J, R\u00f6sch\u00a0W, Reichling\u00a0J, Brignoli\u00a0R, Saller\u00a0R (2004) Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (iberogast). Aliment Pharmacol Ther 20(11\u201312):1279\u20131287","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"1218_CR36","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1046\/j.1365-2036.2002.01322.x","volume":"16","author":"G Holtmann","year":"2002","unstructured":"Holtmann\u00a0G, Gschossmann\u00a0J, Mayr\u00a0P, Talley\u00a0NJ (2002) A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia. Aliment Pharmacol Ther 16(9):1641\u20131648","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"1218_CR37","first-page":"925","volume":"49","author":"A Madisch","year":"1999","unstructured":"Madisch\u00a0A, Heydenreich\u00a0CJ, Wieland\u00a0V, Hufnagel\u00a0R, Hotz\u00a0J (1999) Treatment of functional dyspepsia with a\u00a0fixed peppermint oil and caraway oil combination preparation as compared to cisapride. A multicenter, reference-controlled double-blind euqivalence study. Arzneimittelforschung 49(11):925\u2013932","journal-title":"Arzneimittelforschung"},{"key":"1218_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13132","author":"G Rich","year":"2017","unstructured":"Rich\u00a0G, Shah\u00a0A, Koloski\u00a0N, Funk\u00a0P, Stracke\u00a0B, K\u00f6hler\u00a0S et al (2017) A randomized placebo-controlled trial on the effects of menthacarin, a proprietary peppermint- and a caraway-oil-preparation, on symptoms and quality of life in patients with functional dyspepsia. Neurogastroenterol Motil. https:\/\/doi.org\/10.1111\/nmo.13132","journal-title":"Neurogastroenterol Motil"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-021-01218-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-021-01218-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-021-01218-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T11:03:42Z","timestamp":1642158222000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-021-01218-3"}},"subtitle":["Diagnostik und Therapie","Diagnosis and treatment"],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["1218"],"URL":"https:\/\/doi.org\/10.1007\/s00108-021-01218-3","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"4 November 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>L.\u00a0Gottschalk<\/b>: A.\u00a0Finanzielle Interessen: L.\u00a0Gottschalk gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Angestellte Assistenz\u00e4rztin, Israelitisches Krankenhaus, Hamburg.<b> V.\u00a0Andresen<\/b>: A.\u00a0Finanzielle Interessen: Vortragst\u00e4tigkeiten: Falk, Ferring, Hexal, Kyowa Kirin, Schwabe, Shionogi.\u00a0\u2013 Beratungst\u00e4tigkeiten: Arena, Bayer, Hexal, Kyowa Kirin, 4M\u00a0Medical, Sanofi, Shionogi. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Angestellte Internistin, Hamburg\u00a0| Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS), Deutsche Gesellschaft f\u00fcr Neurogastroenterologie und Motilit\u00e4t (DGNM), Deutsche Gesellschaft f\u00fcr Innere Medizin (DGIM), Deutsche Gesellschaft f\u00fcr Palliativmedizin (DGP).<b> P.\u00a0Layer<\/b>: A.\u00a0Finanzielle Interessen: Referentenhonorare: med update GmbH, Falk Foundation, Medice.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Chefarzt und \u00e4rztlicher Direktor, Medizinische Klinik, Israelitisches Krankenhaus, Hamburg\u00a0| Mitgliedschaften: DGVS (Beirat), Organisator und Sprecher der Steuergruppe der S3-Reizdarm-Leitlinie.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}